Archive for the ‘Zogenix Inc’ Category


July 18th, 2014 | Posted in 2014, Zogenix Inc

A harder-to-abuse, extended-release, version of Zogenix‘s painkiller Zohydro could be reviewed by the FDA this fall and possibly on the market by 2015. The company is also working to develop a tablet version that maintains the extended-release properties even when the drug is crushed or chewed.

Zogenix, Inc

November 20th, 2013 | Posted in 2013, Zogenix Inc

Zogenix – San Diego:  is offering $60-million in stock in a public offering.  The company recently received a FDA approval to sell Zohydro, an opiate painkiller made of pure hydrocodone.

Zogenix Inc

July 18th, 2011 | Posted in 2011, Zogenix Inc

Zogenix Inc.- San Diego:  Signed a deal with Durect Corp, Cupertino, CA., a specialty pharmaceutical company focused on the development of pharmaceutical systems based upon its proprietary drug delivery platform technologies. Under the terms of the agreement, Zogenix will pay an upfront payment of $2.25-million to Durect, with the potential to pay Durect up to an […]